Vasculitis associated with connective tissue disorders

Current Rheumatology Reports

Volumn 8, Issue 4, 2006, Pages 312-316

  Doyle, Mittie K ^a  

^a CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DOUBLE STRANDED DNA ANTIBODY; ENDOTHELIAL CELL ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; SM ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

BEHCET DISEASE; BLOOD VESSEL BIOPSY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MIXED CONNECTIVE TISSUE DISEASE; NERVE BIOPSY; PROGNOSIS; RELAPSING POLYCHONDRITIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS;

ARTHRITIS, RHEUMATOID; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SJOGREN'S SYNDROME; VASCULITIS;

EID: 33750311936     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-006-0015-5     Document Type: Review

References (48)

1. Sneller MC, Fauci AS: Pathogenesis of vasculitis syndromes. Med Clin North Am 1997, 81:221-242.
2. Hunder GG, Arend WP, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990, 33:1065-1067.
3. Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 1997, 337:1512-1523.
4. Gabriel SE, Crowson CS, Kremers HM, et al.: Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003, 48:54-58.
5. Voskuyl AE, Zwinderman AH, Westedt ML, et al.: Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 1996, 55:190-192.
6. Voskuyl AE, Hazes JM, Zwinderman AH, et al.: Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis 2003, 62:407-413.
7. Suzuki A, Ohosone Y, Obana M, et al.: Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 1994, 21:33-36.
8. Liang KP, Liang KV, Matteson EL, et al.: Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum 2006, 54:642-648.
9. Maradit-Kremers H, Nicola PJ, Crowson CS, et al.: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005, 52:722-732.
10. Wallberg-Jonsson S, Cvetkovic JT, Sundqvist KG, et al.: Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol 2002, 29:875-882.
11. Watts RA, Mooney J, Lane SE, Scott DG: Rheumatoid vasculitis: becoming extinct? Rheumatology 2004, 43:920-923.
12. Ward MM: Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum 2004, 50:1122-1131.
13. Turesson C, O'Fallon WM, Crowson CS, et al.: Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002, 29:62-67.
14. Turesson C, McClelland RL, Christianson TJ, Matteson EL: No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum 2004, 50:3729-3731.
15. Jarrett SJ, Cunnane G, Conaghan PG, et al.: Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 2003, 30:2287-2291.
16. van der Bijl AE, Allaart CF, Van Vugt J, et al.: Rheumatoid vasculitis treated with infliximab. J Rheumatol 2005, 32:1607-1609.
17. Langford CA, Sneller MC: Biologic therapies in the vasculitides. Curr Opin Rheumatol 2003, 15:3-10.
18. Belizna CC, Duijvestijn A, Hamidou M, Cohen Tervaert JW: Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis 2006 [Epub ahead of print].
19. van der Zee JM, Heurkens AH, van der Voort EA, et al.: Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Rheumatol 1991, 9:589-594.
20. Heurkens AH, Hiemstra PS, Lafeber GJ, et al.: Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Immunol 1989, 78:7-12.
21. Gorman JD, David-Vaudey E, Pai M, et al.: Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004, 50:3476-3484.
22. Turesson C, Weyand CM, Matteson EL: Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations? Arthritis Rheum 2004, 51:853-863.
23. Weening JJ, D'Agati VD, Schwartz MM, et al.: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004, 65:521-530.
24. Descombes E, Droz D, Drouet L, et al.: Renal vascular lesions in lupus nephritis. Medicine 1997, 76:355-368.
25. Kapoulas S, Liakos S, Karkavelas G, et al.: Thrombotic thrombocytopenic purpura associated with rapidly progressive lupus nephritis: report of two cases. Clin Nephrol 2005, 63:297-301.
26. Drenkard C, Villa AR, Reyes E, et al.: Vasculitis in systemic lupus erythematosus. Lupus 1997, 6:235-242.
27. Cuellar ML, Espinoza LR: Laboratory testing in the evaluation and diagnosis of vasculitis. Curr Rheumatol Rep 2000, 2:417-422.
28. Renaudineau Y, Dugue C, Dueymes M, Youinou P: Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev 2002, 1:365-372.
29. Golan TK: Lupus vasculitis: differential diagnosis with antiphospholipid syndrome. Curr Rheumatol Rep 2002, 4:18-24.
30. Toubi E, Kessel A, Bamberger E, Golan TD: Systemic lupus erythematosus vasculitis: a current therapeutic overview. Curr Treat Options Cardiovasc Med 2004, 6:87-97.
31. Roman MJ, Shanker BA, Davis A, et al.: Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003, 349:2399-2406.
32. Bacon PA: Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheumatol 2005, 17:49-55. An excellent summary on the role that endothelial dysfunction plays in systemic vasculitis and its possible link to cardiovascular disease.
33. Ramos-Casals M, Anaya JM, Garcia-Carrasco M, et al.: Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine 2004, 83:96-106. This is a comprehensive review on cutaneous vasculitis in patients with primary Sjögren's syndrome with biopsy correlation and discussion of clinical relevance to the presence of cryoglobulins and increased mortality.
34. Delalande S, de Seze J, Fauchais AL, et al.: Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine 2004, 83:280-291.
35. Mellgren SI, Conn DL, Stevens JC, Dyck PJ: Peripheral neuropathy in primary Sjogren's syndrome. Neurology 1989, 39:390-394.
36. Turkcapar N, Sak SD, Saatci M, et al.: Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjogren's syndrome. J Rheumatol 2005, 32:1063-1070.
37. Cossio M, Menon Y, Wilson W, deBoisblanc BP: Life-threatening complications of systemic sclerosis. Crit Care Clin 2002, 18:819-839.
38. Maes B, Van Miegham A, Messiaen T, et al.: Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type. Am J Kidney Dis 2000, 36:E16.
39. Dyck PJ, Hunder GG, Dyck PJ: A case-control and nerve biopsy study of CREST multiple mononeuropathy. Neurology 1997, 49:1641-1645.
40. Rho YH, Choi SJ, Lee YH, et al.: Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int 2006, 26:369-375. Case series of 50 cases of scleroderma associated with ANCA-associated vasculitis, with survival analysis and clinical factors associated with the development of ANCA-associated vasculitis in these patients.
41. Yurdakul S, Hamuryudan V, Yazici H: Behcet syndrome. Curr Opin Rheumatol 2004, 16:38-42.
42. Calamia KT, Schirmer M, Melikoglu M: Major vessel involvement in Behcet disease. Curr Opin Rheumatol 2005, 17:1-8.
43. Letko E, Zafirakis P, Baltatzis S, et al.: Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 2002, 31:384-395.
44. Selim AG, Fulford LG, Mohiaddin RH, Sheppard MN: Active aortitis in relapsing polychondritis. J Clin Pathol 2001, 54:890-892.
45. Huerta-Yanez G: Vasculitis en enfermedad mixta del tejido conjuntivo (EMTC) [abstract; in Spanish]. Rev Mex Reumatol 1985, 12:1122-1124.
46. Oh YB, Jun JB, Kim CK: Mixed connective tissue disease associated with skin defects of livedoid vasculitis. Clin Rheumatol 2000, 19:381-384.
47. Geboes K, Dalle I: Vasculitis and the gastrointestinal tract. Acta Gastroenterol Belg 2002, 65:204-212.
48. Feldman D, Hochberg MC, Zizic TM, Stevens MB: Cutaneous vasculitis in adult polymyositis/dermatomyositis. J Rheumatol 1983, 10:85-89.